37
Participants
Start Date
August 31, 2006
Primary Completion Date
November 30, 2006
Study Completion Date
November 30, 2006
insulin detemir
One single dose of insulin detemir produced by current process and the NN729 process injected subcutaneously on two separate dosing visits in varying order
Manchester
Lead Sponsor
Novo Nordisk A/S
INDUSTRY